{"id":345127,"date":"2025-08-24T17:20:05","date_gmt":"2025-08-24T17:20:05","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-pyxis-oncology\/"},"modified":"2025-08-24T17:20:05","modified_gmt":"2025-08-24T17:20:05","slug":"how-to-buy-pyxis-oncology","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/","title":{"rendered":"How to buy Pyxis Oncology, Inc. (PYXS) shares &#8211; Investment in Pyxis Oncology, Inc. (PYXS) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334099,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-345127","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Pyxis Oncology, Inc. (PYXS) Shares - Investment in Pyxis Oncology, Inc. (PYXS) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Pyxis Oncology, Inc. (PYXS) Shares - Investment in Pyxis Oncology, Inc. (PYXS) Stock"},"description":"Learn how to buy Pyxis Oncology, Inc. (PYXS) shares and make informed investment decisions in this promising biotech stock with 547% upside potential according to analysts.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Pyxis Oncology, Inc. (PYXS) shares and make informed investment decisions in this promising biotech stock with 547% upside potential according to analysts."},"intro":"Thinking about investing in the next breakthrough cancer treatment? Pyxis Oncology represents the thrilling world of biotech investing where clinical trial success can transform modest investments into life-changing returns. With a promising antibody-drug conjugate platform and strategic Merck partnership, this company offers both high risk and extraordinary potential reward for savvy investors.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in the next breakthrough cancer treatment? Pyxis Oncology represents the thrilling world of biotech investing where clinical trial success can transform modest investments into life-changing returns. With a promising antibody-drug conjugate platform and strategic Merck partnership, this company offers both high risk and extraordinary potential reward for savvy investors."},"body_html":"<h2>\ud83d\udcc8 Pyxis Oncology Stock: Current Price and Critical Dates<\/h2> <p>As of August 24, 2025, Pyxis Oncology (PYXS) trades at <strong>$1.24<\/strong> per share. Mark your calendar: <strong>November 11, 2025<\/strong> is absolutely critical\u2014that's when Pyxis releases its next quarterly earnings report.<\/p> <h3>How Earnings Reports Move PYXS Stock<\/h3> <p>The biotech sector lives and dies by clinical trial updates and financial results. Looking at recent history:<\/p> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Pre-News Price<\/th><th>Post-News Change<\/th><\/tr> <\/thead> <tbody> <tr><td>Aug 14, 2025<\/td><td>Q2 Earnings<\/td><td>$1.18<\/td><td>+5.1% (mixed reaction)<\/td><\/tr> <tr><td>May 2025<\/td><td>AACR Conference Data<\/td><td>$0.95<\/td><td>+31.6% (positive data)<\/td><\/tr> <tr><td>Feb 2025<\/td><td>Merck Partnership<\/td><td>$1.05<\/td><td>+18.1% (strategic win)<\/td><\/tr> <tr><td>Nov 2024<\/td><td>Phase 1 Initial Data<\/td><td>$1.20<\/td><td>-15.0% (disappointing results)<\/td><\/tr> <tr><td>Aug 2024<\/td><td>Leadership Changes<\/td><td>$1.35<\/td><td>-8.9% (uncertainty)<\/td><\/tr> <tr><td>May 2024<\/td><td>Preclinical Updates<\/td><td>$1.10<\/td><td>+22.7% (promising science)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Insight<\/strong>: Positive clinical data (like AACR 2025) creates explosive moves upward, while any negative trial results cause immediate 15-20% drops. The Merck partnership provided sustained momentum, showing strategic deals matter as much as science.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udd04 6-Month Price Journey (February-August 2025)<\/h2> <p>Pyxis shares have been on a rollercoaster ride:<\/p> <p><strong>February<\/strong>: $1.05 (Merck partnership excitement)<br> <strong>March<\/strong>: $0.88 (market correction, biotech sector weakness)<br> <strong>April<\/strong>: $0.92 (gradual recovery, AACR anticipation)<br> <strong>May<\/strong>: $1.25 (AACR positive data release +31.6% surge)<br> <strong>June<\/strong>: $1.18 (profit-taking, sector rotation)<br> <strong>July<\/strong>: $1.15 (summer doldrums, low volume)<br> <strong>August<\/strong>: $1.24 (Q2 earnings stability)<\/p> <p>The stock gained approximately <strong>18%<\/strong> over this turbulent period, but the real story is the extreme volatility\u2014swings of 30%+ in single months are common in this space.<\/p> <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on current analyst projections and clinical pipeline progress:<\/p> <p><strong>2025 Year-End<\/strong>: $2.50-3.00 (pending November clinical updates) \u2192 <strong>BUY<\/strong><br> <strong>2026<\/strong>: $4.00-6.00 (Phase 2 data expected, potential partnerships)<br> <strong>2028<\/strong>: $8.00-12.00 (Phase 3 initiation, regulatory milestones)<br> <strong>2030<\/strong>: $15.00-20.00 (potential commercialization, revenue generation)<\/p> <p><strong>Verdict<\/strong>: Strong buy for risk-tolerant investors with 2-5 year horizon. Current analyst consensus price target of <a href=\"https:\/\/stockanalysis.com\/stocks\/pyxs\/forecast\/\">$8.67 represents 600%+ upside potential<\/a>.<\/p> <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li><a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-pyxs\/pyxis-oncology\/news\/heres-why-were-watching-pyxis-oncologys-nasdaqpyxs-cash-burn-1\">Only 21 months cash runway<\/a> remaining at current burn rate<\/li> <li>Clinical failure: Any negative trial data could drop stock 50%+ instantly<\/li> <li>Dilution risk: High probability of secondary offering to fund operations<\/li> <li>Sector volatility: Biotech stocks typically swing 3-5x more than broader market<\/li> <\/ul> <h3>Green Lights for 2025-2026<\/h3> <ul> <li><a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/02\/04\/3020191\/0\/en\/Pyxis-Oncology-Initiates-New-PYX-201-Combination-Trial-and-Initiates-Cohort-Expansions-of-Ongoing-Monotherapy-Trial.html\">Phase 1\/2 combination study with KEYTRUDA<\/a> actively recruiting<\/li> <li><a href=\"https:\/\/www.quiverquant.com\/news\/Pyxis+Oncology+Highlights+Promising+Preclinical+Data+for+Micvotabart+Pelidotin+(MICVO)+in+Cancer+Therapy+at+AACR+2025\">Promising AACR 2025 preclinical results<\/a> for MICVO<\/li> <li>Analyst support: 3 buy ratings, $8.67 average price target<\/li> <li>Market position: First-in-class antibody-drug conjugate targeting solid tumors<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start small<\/strong> - Allocate no more than 2-3% of your portfolio to high-risk biotech names<\/li> <li><strong>Use limit orders<\/strong> - Never market order volatile stocks like PYXS<\/li> <li><strong>Set alerts<\/strong> - Monitor for November 11 earnings and any clinical trial announcements<\/li> <li><strong>Diversify timing<\/strong> - Consider buying in thirds over next 3 months to average entry price<\/li> <\/ol> <p>Humorous take: \"Trading PYXS is like watching a medical drama\u2014you need strong nerves for the plot twists, but the season finale could be spectacular!\"<\/p> <h2>\u2705 How to Buy Pyxis Oncology, Inc. (PYXS) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers NASDAQ listings and fractional shares<\/td><\/tr> <tr><td>2<\/td><td>Complete account verification<\/td><td>Most platforms require ID and proof of address<\/td><\/tr> <tr><td>3<\/td><td>Deposit funds<\/td><td>Start with amount you're comfortable risking completely<\/td><\/tr> <tr><td>4<\/td><td>Search \"PYXS\"<\/td><td>Use the ticker symbol, not company name<\/td><\/tr> <tr><td>5<\/td><td>Select order type<\/td><td>Use LIMIT order to control entry price<\/td><\/tr> <tr><td>6<\/td><td>Set share quantity<\/td><td>Consider fractional shares if full share too expensive<\/td><\/tr> <tr><td>7<\/td><td>Review and confirm<\/td><td>Double-check order details before submitting<\/td><\/tr> <tr><td>8<\/td><td>Monitor position<\/td><td>Set price alerts for both upside and downside<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Fits New Biotech Investors<\/h2> <p>For those interested in companies like Pyxis Oncology, Pocket Option offers several advantages:<\/p> <ul> <li><strong>Minimum deposit just $5<\/strong> - Perfect for testing strategies with small positions in volatile stocks<\/li> <li><strong>Rapid verification<\/strong> - Single document KYC process gets you trading quickly<\/li> <li><strong>Fractional shares<\/strong> - Buy portions of expensive stocks without full share cost<\/li> <li><strong>100+ withdrawal methods<\/strong> - Flexibility to access profits through multiple channels<\/li> <\/ul> <h2>\ud83c\udf0d Pyxis Oncology in 2025: Cancer Treatment Innovator<\/h2> <p>Pyxis Oncology is revolutionizing cancer treatment with its innovative antibody-drug conjugate platform targeting solid tumors. The company's lead candidate, MICVO (formerly PYX-201), represents a first-in-class approach that could transform how we treat recurrent head and neck cancers.<\/p> <p><strong>2025 fun fact<\/strong>: Pyxis scientists discovered that their antibody platform accidentally works better in combination with existing therapies\u2014leading to the strategic Merck partnership that might never have happened without this happy accident!<\/p> <p>For more insights on trading strategies and market analysis, visit the <a href=\"\/blog\">Pocket Option blog<\/a> for educational content designed for new investors.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Pyxis Oncology Stock: Current Price and Critical Dates<\/h2>\n<p>As of August 24, 2025, Pyxis Oncology (PYXS) trades at <strong>$1.24<\/strong> per share. Mark your calendar: <strong>November 11, 2025<\/strong> is absolutely critical\u2014that&#8217;s when Pyxis releases its next quarterly earnings report.<\/p>\n<h3>How Earnings Reports Move PYXS Stock<\/h3>\n<p>The biotech sector lives and dies by clinical trial updates and financial results. Looking at recent history:<\/p>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Pre-News Price<\/th>\n<th>Post-News Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Aug 14, 2025<\/td>\n<td>Q2 Earnings<\/td>\n<td>$1.18<\/td>\n<td>+5.1% (mixed reaction)<\/td>\n<\/tr>\n<tr>\n<td>May 2025<\/td>\n<td>AACR Conference Data<\/td>\n<td>$0.95<\/td>\n<td>+31.6% (positive data)<\/td>\n<\/tr>\n<tr>\n<td>Feb 2025<\/td>\n<td>Merck Partnership<\/td>\n<td>$1.05<\/td>\n<td>+18.1% (strategic win)<\/td>\n<\/tr>\n<tr>\n<td>Nov 2024<\/td>\n<td>Phase 1 Initial Data<\/td>\n<td>$1.20<\/td>\n<td>-15.0% (disappointing results)<\/td>\n<\/tr>\n<tr>\n<td>Aug 2024<\/td>\n<td>Leadership Changes<\/td>\n<td>$1.35<\/td>\n<td>-8.9% (uncertainty)<\/td>\n<\/tr>\n<tr>\n<td>May 2024<\/td>\n<td>Preclinical Updates<\/td>\n<td>$1.10<\/td>\n<td>+22.7% (promising science)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Insight<\/strong>: Positive clinical data (like AACR 2025) creates explosive moves upward, while any negative trial results cause immediate 15-20% drops. The Merck partnership provided sustained momentum, showing strategic deals matter as much as science.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 6-Month Price Journey (February-August 2025)<\/h2>\n<p>Pyxis shares have been on a rollercoaster ride:<\/p>\n<p><strong>February<\/strong>: $1.05 (Merck partnership excitement)<br \/> <strong>March<\/strong>: $0.88 (market correction, biotech sector weakness)<br \/> <strong>April<\/strong>: $0.92 (gradual recovery, AACR anticipation)<br \/> <strong>May<\/strong>: $1.25 (AACR positive data release +31.6% surge)<br \/> <strong>June<\/strong>: $1.18 (profit-taking, sector rotation)<br \/> <strong>July<\/strong>: $1.15 (summer doldrums, low volume)<br \/> <strong>August<\/strong>: $1.24 (Q2 earnings stability)<\/p>\n<p>The stock gained approximately <strong>18%<\/strong> over this turbulent period, but the real story is the extreme volatility\u2014swings of 30%+ in single months are common in this space.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on current analyst projections and clinical pipeline progress:<\/p>\n<p><strong>2025 Year-End<\/strong>: $2.50-3.00 (pending November clinical updates) \u2192 <strong>BUY<\/strong><br \/> <strong>2026<\/strong>: $4.00-6.00 (Phase 2 data expected, potential partnerships)<br \/> <strong>2028<\/strong>: $8.00-12.00 (Phase 3 initiation, regulatory milestones)<br \/> <strong>2030<\/strong>: $15.00-20.00 (potential commercialization, revenue generation)<\/p>\n<p><strong>Verdict<\/strong>: Strong buy for risk-tolerant investors with 2-5 year horizon. Current analyst consensus price target of <a href=\"https:\/\/stockanalysis.com\/stocks\/pyxs\/forecast\/\">$8.67 represents 600%+ upside potential<\/a>.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li><a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-pyxs\/pyxis-oncology\/news\/heres-why-were-watching-pyxis-oncologys-nasdaqpyxs-cash-burn-1\">Only 21 months cash runway<\/a> remaining at current burn rate<\/li>\n<li>Clinical failure: Any negative trial data could drop stock 50%+ instantly<\/li>\n<li>Dilution risk: High probability of secondary offering to fund operations<\/li>\n<li>Sector volatility: Biotech stocks typically swing 3-5x more than broader market<\/li>\n<\/ul>\n<h3>Green Lights for 2025-2026<\/h3>\n<ul>\n<li><a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/02\/04\/3020191\/0\/en\/Pyxis-Oncology-Initiates-New-PYX-201-Combination-Trial-and-Initiates-Cohort-Expansions-of-Ongoing-Monotherapy-Trial.html\">Phase 1\/2 combination study with KEYTRUDA<\/a> actively recruiting<\/li>\n<li><a href=\"https:\/\/www.quiverquant.com\/news\/Pyxis+Oncology+Highlights+Promising+Preclinical+Data+for+Micvotabart+Pelidotin+(MICVO)+in+Cancer+Therapy+at+AACR+2025\">Promising AACR 2025 preclinical results<\/a> for MICVO<\/li>\n<li>Analyst support: 3 buy ratings, $8.67 average price target<\/li>\n<li>Market position: First-in-class antibody-drug conjugate targeting solid tumors<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start small<\/strong> &#8211; Allocate no more than 2-3% of your portfolio to high-risk biotech names<\/li>\n<li><strong>Use limit orders<\/strong> &#8211; Never market order volatile stocks like PYXS<\/li>\n<li><strong>Set alerts<\/strong> &#8211; Monitor for November 11 earnings and any clinical trial announcements<\/li>\n<li><strong>Diversify timing<\/strong> &#8211; Consider buying in thirds over next 3 months to average entry price<\/li>\n<\/ol>\n<p>Humorous take: &#8220;Trading PYXS is like watching a medical drama\u2014you need strong nerves for the plot twists, but the season finale could be spectacular!&#8221;<\/p>\n<h2>\u2705 How to Buy Pyxis Oncology, Inc. (PYXS) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NASDAQ listings and fractional shares<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete account verification<\/td>\n<td>Most platforms require ID and proof of address<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Deposit funds<\/td>\n<td>Start with amount you&#8217;re comfortable risking completely<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Search &#8220;PYXS&#8221;<\/td>\n<td>Use the ticker symbol, not company name<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Select order type<\/td>\n<td>Use LIMIT order to control entry price<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Set share quantity<\/td>\n<td>Consider fractional shares if full share too expensive<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Review and confirm<\/td>\n<td>Double-check order details before submitting<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Monitor position<\/td>\n<td>Set price alerts for both upside and downside<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits New Biotech Investors<\/h2>\n<p>For those interested in companies like Pyxis Oncology, Pocket Option offers several advantages:<\/p>\n<ul>\n<li><strong>Minimum deposit just $5<\/strong> &#8211; Perfect for testing strategies with small positions in volatile stocks<\/li>\n<li><strong>Rapid verification<\/strong> &#8211; Single document KYC process gets you trading quickly<\/li>\n<li><strong>Fractional shares<\/strong> &#8211; Buy portions of expensive stocks without full share cost<\/li>\n<li><strong>100+ withdrawal methods<\/strong> &#8211; Flexibility to access profits through multiple channels<\/li>\n<\/ul>\n<h2>\ud83c\udf0d Pyxis Oncology in 2025: Cancer Treatment Innovator<\/h2>\n<p>Pyxis Oncology is revolutionizing cancer treatment with its innovative antibody-drug conjugate platform targeting solid tumors. The company&#8217;s lead candidate, MICVO (formerly PYX-201), represents a first-in-class approach that could transform how we treat recurrent head and neck cancers.<\/p>\n<p><strong>2025 fun fact<\/strong>: Pyxis scientists discovered that their antibody platform accidentally works better in combination with existing therapies\u2014leading to the strategic Merck partnership that might never have happened without this happy accident!<\/p>\n<p>For more insights on trading strategies and market analysis, visit the <a href=\"\/blog\">Pocket Option blog<\/a> for educational content designed for new investors.<\/p>\n"},"faq":[{"question":"What is Pyxis Oncology's main drug candidate?","answer":"MICVO (micvotabart pelidotin), an antibody-drug conjugate targeting solid tumors, currently in Phase 1\/2 trials."},{"question":"How much cash does Pyxis have remaining?","answer":"Approximately $90 million as of Q2 2025, providing runway into late 2026."},{"question":"Why is the Merck partnership important?","answer":"It combines Pyxis's novel therapy with Merck's established KEYTRUDA, potentially enhancing efficacy for cancer patients."},{"question":"What percentage upside do analysts project?","answer":"Average price target of $8.67 represents about 600% upside from current levels."},{"question":"When are the next major clinical updates expected?","answer":"Significant data expected in late 2025 and early 2026 from ongoing trials."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What is Pyxis Oncology's main drug candidate?","answer":"MICVO (micvotabart pelidotin), an antibody-drug conjugate targeting solid tumors, currently in Phase 1\/2 trials."},{"question":"How much cash does Pyxis have remaining?","answer":"Approximately $90 million as of Q2 2025, providing runway into late 2026."},{"question":"Why is the Merck partnership important?","answer":"It combines Pyxis's novel therapy with Merck's established KEYTRUDA, potentially enhancing efficacy for cancer patients."},{"question":"What percentage upside do analysts project?","answer":"Average price target of $8.67 represents about 600% upside from current levels."},{"question":"When are the next major clinical updates expected?","answer":"Significant data expected in late 2025 and early 2026 from ongoing trials."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Pyxis Oncology, Inc. (PYXS) shares - Investment in Pyxis Oncology, Inc. (PYXS) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Pyxis Oncology, Inc. (PYXS) shares - Investment in Pyxis Oncology, Inc. (PYXS) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-24T17:20:05+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Pyxis Oncology, Inc. (PYXS) shares &#8211; Investment in Pyxis Oncology, Inc. (PYXS) stock\",\"datePublished\":\"2025-08-24T17:20:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/\"},\"wordCount\":17,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/\",\"name\":\"How to buy Pyxis Oncology, Inc. (PYXS) shares - Investment in Pyxis Oncology, Inc. (PYXS) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"datePublished\":\"2025-08-24T17:20:05+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Pyxis Oncology, Inc. (PYXS) shares &#8211; Investment in Pyxis Oncology, Inc. (PYXS) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Pyxis Oncology, Inc. (PYXS) shares - Investment in Pyxis Oncology, Inc. (PYXS) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Pyxis Oncology, Inc. (PYXS) shares - Investment in Pyxis Oncology, Inc. (PYXS) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-24T17:20:05+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Pyxis Oncology, Inc. (PYXS) shares &#8211; Investment in Pyxis Oncology, Inc. (PYXS) stock","datePublished":"2025-08-24T17:20:05+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/"},"wordCount":17,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/","name":"How to buy Pyxis Oncology, Inc. (PYXS) shares - Investment in Pyxis Oncology, Inc. (PYXS) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","datePublished":"2025-08-24T17:20:05+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-pyxis-oncology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Pyxis Oncology, Inc. (PYXS) shares &#8211; Investment in Pyxis Oncology, Inc. (PYXS) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":345189,"slug":"how-to-buy-pyxis-oncology","post_title":"Comment acheter des actions Pyxis Oncology, Inc. (PYXS) - Investir dans les actions Pyxis Oncology, Inc. (PYXS)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-pyxis-oncology\/"},"it_IT":{"locale":"it_IT","id":345188,"slug":"how-to-buy-pyxis-oncology","post_title":"Come acquistare azioni Pyxis Oncology, Inc. (PYXS) - Investire in azioni Pyxis Oncology, Inc. (PYXS)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-pyxis-oncology\/"},"pl_PL":{"locale":"pl_PL","id":345192,"slug":"how-to-buy-pyxis-oncology","post_title":"Jak kupi\u0107 akcje Pyxis Oncology, Inc. (PYXS) - Inwestycja w akcje Pyxis Oncology, Inc. (PYXS)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-pyxis-oncology\/"},"es_ES":{"locale":"es_ES","id":345191,"slug":"how-to-buy-pyxis-oncology","post_title":"C\u00f3mo comprar acciones de Pyxis Oncology, Inc. (PYXS) - Inversi\u00f3n en acciones de Pyxis Oncology, Inc. (PYXS)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-pyxis-oncology\/"},"th_TH":{"locale":"th_TH","id":345195,"slug":"how-to-buy-pyxis-oncology","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Pyxis Oncology, Inc. (PYXS) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Pyxis Oncology, Inc. (PYXS)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-pyxis-oncology\/"},"tr_TR":{"locale":"tr_TR","id":345194,"slug":"how-to-buy-pyxis-oncology","post_title":"Pyxis Oncology, Inc. (PYXS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Pyxis Oncology, Inc. (PYXS) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-pyxis-oncology\/"},"vt_VT":{"locale":"vt_VT","id":345190,"slug":"how-to-buy-pyxis-oncology","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Pyxis Oncology, Inc. (PYXS)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-pyxis-oncology\/"},"pt_AA":{"locale":"pt_AA","id":345193,"slug":"how-to-buy-pyxis-oncology","post_title":"Como comprar a\u00e7\u00f5es da Pyxis Oncology, Inc. (PYXS) - Investimento em a\u00e7\u00f5es da Pyxis Oncology, Inc. (PYXS)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-pyxis-oncology\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/345127","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=345127"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/345127\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334099"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=345127"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=345127"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=345127"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}